Shasun Pharmaceuticals Ltd Merged Quarterly Results

Gross Sales

323.32

319.17

336.1

310.05

306.03

Excise Duty

0

0

0

0

0

Net Sales

323.32

319.17

336.1

310.05

306.03

Other Operating Income

15.98

14.4

21.85

14.95

13.93

Other Income

4.08

1.09

12.33

1.58

4.26

Total Income

343.38

334.66

370.28

326.58

324.22

Total Expenditure

301.81

302.85

317.39

292.32

300.56

PBIDT

41.57

31.81

52.89

34.26

23.66

Interest

11.55

12.36

12.9

15.69

12.36

PBDT

30.02

19.45

39.99

18.57

11.3

Depreciation

15.29

14.46

12.94

11.76

9.98

Minority Interest Before NP

0

0

0

0

0

Tax

1.63

1.18

6.31

0

0.02

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

13.1

3.81

20.74

6.81

1.3

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

13.09

3.8

22.16

6.14

0.25

Extra-ordinary Items

0

0

6.02

0

0

Adjusted Profit After Extra-ordinary item

13.09

3.8

16.14

6.14

0.25

EPS (Unit Curr.)

1.95

0.61

3.69

1.02

0.04

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

50

0

0

0

Equity

13.45

13.45

12.03

12.03

12.03

Public Shareholding (Number)

4,34,80,992

4,34,80,992

3,63,80,992

3,63,80,992

3,63,80,992

Public Shareholding (%)

64.68

64.68

60.51

60.51

60.51

Pledged/Encumbered - No. of Shares

41,12,000

43,72,000

31,18,296

29,18,296

41,02,000

Pledged/Encumbered - % in Total Promoters Holding

17.32

18.41

13.13

12.29

17.28

Pledged/Encumbered - % in Total Equity

6.12

6.5

5.19

4.85

6.82

Non Encumbered - No. of Shares

1,96,30,862

1,93,70,862

2,06,24,566

2,08,24,566

1,96,40,862

Non Encumbered - % in Total Promoters Holding

82.68

81.59

86.87

87.71

82.72

Non Encumbered - % in Total Equity

29.2

28.82

34.3

34.64

32.67

PBIDTM(%)

12.85

9.96

15.73

11.04

7.73

PBDTM(%)

9.28

6.09

11.89

5.98

3.69

PATM(%)

4.05

1.19

6.17

2.19

0.42